ANI Pharmaceuticals Inc (ANIP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

210 MAIN STREET WEST BAUDETTE, MN 56623

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products.

Data as of 2021-05-08 10:18:09 -0400
Market Cap491.342 Million Shares Outstanding12.729 Million Avg 30-day Volume50.902 Thousand
P/E Ratio-21.79094 Dividend Yield EPS-1.88
Price/Sales2.36 Debt to Equity2.36 EBITDA40.331 Million
Price to Book Value2.51 Forward PE Enterprise Value669.164 Million
Total Cash7.864 Million Current Debt78.565 Million Gross Profit121.318 Million
BETA1.16788 52-week High/Low40.0 / 23.55 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ANIP instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 117 115 1.74% 31 (1.86%) 28 (1.74%) 10.71%
13F shares: 7.37 Million 7.263 Million 1.47% 2.009 Million 2.108 Million -4.72%
% Ownership 59.689 58.8229 1.47% 16.2694 17.0746 -4.72%
New Positions: 17 10 70.0% 8 3 166.67%
Increased Positions 39 44 -11.36% 11 8 37.5%
Closed Positions 14 29 -51.72% 5 14 -64.29%
Reduced Positions 42 37 13.51% 10 15 -33.33%
Total Calls 35.924 Thousand 70.157 Thousand -48.79% 25.6 Thousand 69.5 Thousand -63.17%
Total Puts 22.842 Thousand 30.2 Thousand -24.36% 3.6 Thousand 7.2 Thousand -50.0%
PUT/CALL Ratio 0.64 0.43 48.84% 0.14 0.1 40.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ANIP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANIP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

4 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARKEN JAMES G. SVP OPS & PROD DEV

114,321 2021-04-12 4

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

112,500 2021-04-12 4

SCHREPFER ROBERT W SVP - NEW BUS DEV & SPEC SALES

87,477 2021-03-29 1

BROWN ROBERT E. JR

38,972 2021-03-23 1

NASH DAVID

21,647 2021-03-23 1

HAUGHEY THOMAS

27,702 2021-03-23 1

WALSH PATRICK D

48,388 2021-03-23 4

THOMA JEANNE

16,713 2021-03-23 3

PERA ANTONIO R

16,713 2021-03-23 3

LALWANI NIKHIL PRESIDENT & CEO

165,003 2021-03-23 3

GUTWERG ORI SVP, GENERICS

0 2021-02-15 2

MUTZ CHRISTOPHER CHIEF COMMERCIAL OFFICER

0 2021-02-15 2

PRZYBYL ARTHUR PRESIDENT AND CEO

  • Officer
  • Director
190,309 2020-04-06 0

MERIDIAN VENTURE PARTNERS II LP

MERIDIAN VENTURE PARTNERS II GP, L.P.

MERIDIAN VENTURE PARTNERS II, CO.

BROWN ROBERT E. JR

  • Director
  • 10% Owner
2,281,283 2019-08-19 0

PENN THOMAS A.

  • Director
14,301 2019-03-28 0

MARSHBANKS TRACY

  • Director
349,934 2018-05-14 0

HOLUBOW FRED

  • Director
14,811 2018-03-20 0

RAYNOR DANIEL

  • Director
289,003 2018-03-15 0

ARNOLD CHARLOTTE C. VICE PRESIDENT AND CFO

  • Officer
54,298 2016-04-07 0

LANKAU PETER A

  • Director
2,500 2016-04-07 0

MANGANO ROSS J

  • Director
26,914 2014-09-15 0

JAMNICK ROBERT J. VP, QUALITY & PRODUCT DEVELOP.

  • Officer
48,118 2014-05-22 0

BROWN ROBERT E. JR

PENN THOMAS A.

  • Director
  • 10% Owner
16,918,469 2013-06-19 0

MERIDIAN VENTURE PARTNERS II LP

MERIDIAN VENTURE PARTNERS II GP, L.P.

MERIDIAN VENTURE PARTNERS II, CO.

  • 10% Owner
16,918,469 2013-06-19 0

ROSENOW EDWARD C III

  • Director
20,540 2012-03-30 0

SULLIVAN LOUIS W

  • Director
47,898 2012-03-30 0

SHERWIN STEPHEN A

  • Director
86,760 2012-03-30 0

POTTS JOHN T JR

  • Director
5,581 2012-03-30 0

SIMES STEPHEN M VICE CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
202,267 2012-01-25 0

DONENBERG PHILIP B SR VP OF FINANCE, CFO, SECY

  • Officer
44,322 2012-01-25 0

SNABES MICHAEL C SR. VP OF MEDICAL AFFAIRS

  • Officer
0 2012-01-25 0

KJAER PETER

  • Director
34,425 2010-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MARKEN JAMES G. SVP OPS & PROD DEV

2021-04-13 17:26:29 -0400 2021-04-12 F 1,878 $31.86 d 114,321 direct 3.1454 1.4243 3.1454 2 -2.0475 5

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

2021-04-13 17:25:22 -0400 2021-04-12 F 3,042 $31.86 d 112,500 direct 3.1454 1.4243 3.1454 2 -2.0475 5

MARKEN JAMES G. SVP OPS & PROD DEV

2021-04-07 20:29:07 -0400 2021-04-06 F 337 $33.69 d 116,199 direct -0.3129 8.761 8.761 6 -0.3129 2

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

2021-04-07 20:19:13 -0400 2021-04-06 F 612 $33.69 d 115,542 direct -0.3129 8.761 8.761 6 -0.3129 2

MARKEN JAMES G. SVP OPS & PROD DEV

2021-03-31 20:57:41 -0400 2021-03-31 F 278 $36.14 d 116,536 direct -0.8522 -6.3767 0.0 1 -6.3767 6

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

2021-03-31 20:56:32 -0400 2021-03-31 F 508 $36.14 d 116,154 direct -0.8522 -6.3767 0.0 1 -6.3767 6

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

2021-03-31 20:56:32 -0400 2021-03-29 F 953 $32.68 d 116,662 direct -0.8522 -6.3767 0.0 1 -6.3767 6

MARKEN JAMES G. SVP OPS & PROD DEV

2021-03-31 20:57:41 -0400 2021-03-29 F 524 $32.68 d 116,814 direct -0.8522 -6.3767 0.0 1 -6.3767 6

SCHREPFER ROBERT W SVP - NEW BUS DEV & SPEC SALES

2021-03-29 20:11:23 -0400 2021-03-29 F 5,566 $32.68 d 87,477 direct 9.7146 -2.459 9.7146 2 -2.459 6

NASH DAVID

2021-03-25 16:38:24 -0400 2021-03-23 A 9,292 a 21,647 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

LALWANI NIKHIL PRESIDENT & CEO

2021-03-25 16:43:04 -0400 2021-03-23 A 136,495 a 165,003 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

BROWN ROBERT E. JR

2021-03-25 16:36:05 -0400 2021-03-23 A 9,292 a 38,972 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

THOMA JEANNE

2021-03-25 16:39:59 -0400 2021-03-23 A 9,292 a 16,713 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

CAREY STEPHEN P. SENIOR VICE PRESIDENT AND CFO

2021-03-25 16:44:42 -0400 2021-03-23 A 54,470 a 117,615 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

HAUGHEY THOMAS

2021-03-25 16:37:13 -0400 2021-03-23 A 9,292 a 27,702 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

WALSH PATRICK D

2021-03-25 16:34:49 -0400 2021-03-23 A 9,292 a 48,388 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

PERA ANTONIO R

2021-03-25 16:41:49 -0400 2021-03-23 A 9,292 a 16,713 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

MARKEN JAMES G. SVP OPS & PROD DEV

2021-03-25 16:45:52 -0400 2021-03-23 A 32,041 a 117,338 direct -0.0612 3.2436 0.6732 18.1151 30 -2.5092 10

WALSH PATRICK D

2021-03-17 19:55:50 -0400 2021-03-15 P 4,000 $32.89 a 39,096 direct 4.0303 -4.8182 0.8485 9.5152 10 -5.8485 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ANI PHARMACEUTICALS INC ANIP 2021-05-11 22:15:03 UTC -0.3623 0.4123 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 21:45:03 UTC -0.3392 0.3892 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 21:15:03 UTC -0.3392 0.3892 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 20:45:03 UTC -0.3392 0.3892 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 20:15:03 UTC -0.3392 0.3892 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 19:45:03 UTC -0.3392 0.3892 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 19:15:02 UTC -0.3392 0.3892 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 18:45:02 UTC -0.2587 0.3087 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 18:15:03 UTC -0.2587 0.3087 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 17:45:03 UTC -0.2587 0.3087 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 17:15:04 UTC -0.2587 0.3087 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 16:45:04 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 16:15:04 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 15:45:03 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 15:15:03 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 14:45:03 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 14:15:03 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 13:45:04 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 13:15:04 UTC -0.304 0.354 550000
ANI PHARMACEUTICALS INC ANIP 2021-05-11 12:45:03 UTC -0.304 0.354 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund ANIP -66.0 shares, $-2688.84 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ANIP -42.0 shares, $-1711.08 2020-03-31 N-PORT

Elevate your investments